Gene expression-directed chemotherapy improves CUP patient survival

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Oct 22 / Springer Healthcare

Gene expression-directed chemotherapy improves CUP patient survival

Oncology Solid Tumours ESMO-2023

Description

Professor Zhiguo Luo shares phase 3 trial findings showing that a 90-gene expression assay can aid choice of chemotherapy and improve survival for patients with cancer of unknown primary.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.